DGXQuest Diagnostics
What is the market doing?
No clear lean: rangebound and insiders net selling (often routine).
Choppy, but holding above its 200-day average. Price is +13% vs its 200-day average.
Insiders were net sellers over the 90 days ending Oct 8, 2026; selling is often routine (taxes, diversification).
Moderately shorted, settled Sep 15, 2026, about a week of normal trading to cover. Up 4.5% since the previous count, up from 3.1% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How DGX is trading
Quest Diagnostics is +28% over the past year while the S&P 500 is +18%: 9.5 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +13%
vs 200-day average · a clear uptrend
- RSI (14)
- 32
RSI (14) · neutral
- Below its 52-week high
- 6.6%
Below its 52-week high
Details›
- Last close2026-10-09
- $231.15
- 1 monthS&P 500 +2.7%
- +0.03%
- 1 yearS&P 500 +18%
- +28%
- 5 yearsS&P 500 +88%
- +65%
- vs 50-day average$237.27
- −2.6%
- 52-week high
- $247.58
- 52-week low
- $171.95
- Annualised volatility
- 24%
| Year | Return |
|---|---|
| 2026 (year to date) | +34% |
| 2025 | +17% |
| 2024 | +12% |
| 2023 | −10% |
| 2022 | −7.8% |
| 2021 | +48% |
| 2020 | +14% |
| 2019 | +31% |
| 2018 | −14% |
| 2017 | +9.2% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +1.1% |
| Feb | 10 | 3 of 10 | −0.52% |
| Mar | 10 | 6 of 10 | −0.78% |
| Apr | 10 | 7 of 10 | +6.5% |
| May | 10 | 6 of 10 | +1.6% |
| Jun | 10 | 7 of 10 | +1.3% |
| Jul | 11 | 7 of 11 | +3.4% |
| Aug | 11 | 7 of 11 | +0.31% |
| Sep | 11 | 4 of 11 | −1.7% |
| Oct | 11 | 6 of 11 | +0.49% |
| Nov | 10 | 9 of 10 | +3.8% |
| Dec | 10 | 6 of 10 | −0.02% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Diagnostics & Research
The closest names by size in the same industry